Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-17T23:17:01.603Z Has data issue: false hasContentIssue false
  • English
  • Français

Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder

Published online by Cambridge University Press:  12 August 2013

Clarissa M. Comim ,
Karin M. Gomes ,
Gislaine Z. Réus ,
Fabrícia Petronilho ,
Gabriela K. Ferreira ,
Emílio L. Streck ,
Felipe Dal-Pizzol  and
João Quevedo
Clarissa M. Comim*
Affiliation:
Laboratory of Neurosciences, Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
Karin M. Gomes
Affiliation:
Laboratory of Neurosciences, Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
Gislaine Z. Réus
Affiliation:
Laboratory of Neurosciences, Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
Fabrícia Petronilho
Affiliation:
Laboratory of Experimental Pathophysiology, Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
Gabriela K. Ferreira
Affiliation:
Laboratory of Experimental Pathophysiology, Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
Emílio L. Streck
Affiliation:
Laboratory of Experimental Pathophysiology, Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
Felipe Dal-Pizzol
Affiliation:
Laboratory of Experimental Pathophysiology, Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
João Quevedo
Affiliation:
Laboratory of Neurosciences, Postgraduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil
*
Prof. Clarissa M. Comim, PhD, Laboratory of Neuroscience, PPGCS, UNASAU, University of Southern Santa Catarina, 88806-000 Criciúma, SC, Brazil. Tel/Fax: +55 48 3431 2736; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives

To evaluate oxidative damage through the thiobarbituric acid-reactive species (TBARS) and protein carbonyl groups; antioxidant enzymatic system – superoxide dismutase (SOD) and catalase (CAT); and energetic metabolism in the brain of spontaneously hypertensive adult rats (SHR) after both acute and chronic treatment with methylphenidate hydrochloride (MPH).

Methods

Adult (60 days old) SHRs were treated during 28 days (chronic treatment), or 1 day (acute treatment). The rats received one i.p. injection per day of either saline or MPH (2 mg/kg). Two hours after the last injection, oxidative damage parameters and energetic metabolism in the cerebellum, prefrontal cortex, hippocampus, striatum and cortex were evaluated.

Results

We observed that both acute and/or chronic treatment increased TBARS and carbonyl groups, and decreased SOD and CAT activities in many of the brain structures evaluated. Regarding the energetic metabolism evaluation, the acute and chronic treatment altered the energetic metabolism in many of the brain structures evaluated.

Conclusion

We observed that both acute and chronic use of methylphenidate hydrochloride (MPH) in adult spontaneously hypertensive rats (SHRs) was associated with increased oxidative stress and energetic metabolism alterations. These data also reinforce the importance of the SHR animal model in further studies regarding MPH.

Keywords

energetic metabolismmethylphenidateoxidative stressSHR rats
Type
Original Articles
Information
Acta Neuropsychiatrica , Volume 26 , Issue 2 , April 2014 , pp. 96 - 103
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Faraone, SV, Sergeant, J, Gillberg, C, Biederman, J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2003;2:104–113.Google ScholarPubMed
2.Faraone, SV. Genetics of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004;27:303–321.Google Scholar
3.Wilens, TE. Pharmacotherapy of ADHD in adults. CNS Spectr 2008;13:11–13.CrossRefGoogle ScholarPubMed
4.Volkow, ND, Fowler, JS, Wang, G, Ding, Y, Gatley, SJ. Mechanism of action of methylphenidate: insights from PET imaging studies. J Atten Disord 2002;1:S31–S43.Google Scholar
5.Kuczenski, R, Segal, DS. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 1997;68:2032–2037.Google Scholar
6.Kuczenski, R, Segal, DS. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 2001;296:876–883.Google ScholarPubMed
7.Kuczenski, R, Segal, DS. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci 2002;22:7264–7271.CrossRefGoogle ScholarPubMed
8.Volkow, ND, Wang, G, Fowler, JS, Logan, J, Gerasimov, M, Maynard, L. Therapeutic doses of oral methylphenidate significantly increases extracellular dopamine in the human brain. J Neurosci 2001;21:121.Google Scholar
9.Floyd, RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999;222:236–245.CrossRefGoogle ScholarPubMed
10.Porrino, LJ, Lucignani, G. Different patterns of local brain energy metabolism associated with high and low doses of methylphenidate, Relevance to its action in hyperactive children. Biol Psychiatr 1987;22:126–138.Google Scholar
11.Brown, JM, Yamamoto, BK. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol Ther 2003;99:45–53.Google Scholar
12.Fukami, G, Hashimoto, K, Koike, K, Okamura, N, Shimizu, E, Iyo, M. Effect of antioxidant N-acetyl-l-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Res 2004;1016:90–95.Google Scholar
13.Robinson, TE, Becker, JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 1986;11:157–198.Google Scholar
14.Carlezon, WA Jr, Nestler, EJ. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci 2002;25:610–615.Google Scholar
15.Nestler, EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev, Neurosci 2001;2:119–128.Google Scholar
16.Robinson, TE, Berridge, KC. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000;95:91–117.Google Scholar
17.Koob, GF, Sanna, PP, Bloom, EE. Neuroscience of addiction. Neuron 1998;21:467–476.Google Scholar
18.Russell, VA, Johansen, EB, Sagvolden, T. Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct 2005;15:1–9.Google Scholar
19.Sagvolden, T, Russell, VA, Aase, A, Johansen, EB, Farshbaf, M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57:1239–1247.Google Scholar
20.Heal, DJ, Smith, SL, Kulkarni, RS, Rowley, HL. New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD. Pharmacol Biochem Behav 2008;90:184–197.Google Scholar
21.Ceylan, M, Sener, S, Bayraktar, AC, Kavutcu, M. Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2010;1:1491–1494.Google Scholar
22.Selek, S, Savas, HA, Gergerlioglu, HS, Bulut, M, Yilmaz, HR. Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biol Psychol 2008;79:256–259.Google Scholar
23.Gomes, KM, Souza, RP, Valvassori, SSet al. Chronic methylphenidate-effects over circadian cycle of young and adult rats submitted to open-field and object recognition tests. Curr Neurovasc Res 2009;6:259–266.Google Scholar
24.Gomes, KM, Comim, CM, Valvassori, SSet al. Diurnal differences in memory and learning in young and adult rats treated with methylphenidate. J Neural Transm 2010;117:457–462.CrossRefGoogle Scholar
25.Gomes, KM, Souza, RP, Inácio, CGet al. Evaluation of light/dark cycle in anxiety- and depressive-like behaviors after regular treatment with methylphenidate hydrochloride in rats of different ages. Rev Bras Psiquiatr 2011;33:55–58.Google Scholar
26.Esterbauer, H, Cheeseman, KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407–421.Google Scholar
27.Levine, RL, Williams, JA, Stadtman, ER, Shacter, E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994;233:346–357.Google Scholar
28.Bannister, JV, Calabrese, L. Assays for superoxide dismutase. Methods Biochem Anal 1987;32:279–312.Google Scholar
29.Aebi, H. Catalase in vitro. Methods Enzymol 1984;105:121–126.Google Scholar
30.Lowry, OH, Rosebrough, NJ, Farr, AL, Randall, RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.Google Scholar
31.Comim, CM, Rezin, GT, Scaini, Get al. Mitochondrial respiratory chain and creatine kinase activities in rat brain after sepsis induced by cecal ligation and perforation. Mitochondrion 2008;8:313–318.Google Scholar
32.Volkow, ND, Wang, G, Fowler, JS, Ding, Y. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57:1410–1415.Google Scholar
33.Schweitzer, JB, Lee, DO, Hanford, RBet al. Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity. Biol Psychiatry 2004;56:597–606.CrossRefGoogle Scholar
34.Lou, H. Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD); significance of prematurity and perinatal hypoxic- haemodynamic encephalopathy. Acta Paediatr 1996;85:1266–1271.Google Scholar
35.Alexander, GE, Delong, MR, Strick, PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357–381.CrossRefGoogle ScholarPubMed
36.Dougherty, DD, Bonab, AA, Spencer, J, Rauch, SL, Madras, BK, Fischman, AJ. Dopamine transporter density is elevated in patients with ADHD. Lancet 1999;354:2132–2133.Google Scholar
37.Schmahmann, JD, Sherman, JC. The cerebellar cognitive affective syndrome. Brain 1998;121:561–579.Google Scholar
38.Middleton, FA, Strick, PL. Cerebellar projections to the prefrontal cortex of the primate. J Neurosci 2001;21:700–712.Google Scholar
39.Federici, M, Geracitano, R, Bernardi, G, Mercuri, MB. Actions ofmethylphenidate on dopaminergic neurons of the ventral midbrain. Biol Psychiatry 2005;57:361–365.Google Scholar
40.Lavoie, MJ, Hastings, TG. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity o methamphetamine: evidence against a role for extracellular dopamine. J Neurosc 1999;19:1484–1491.Google Scholar
41.Riddle, EL, Hanson, GR, Fleckenstein, AE. Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter. Eur J Pharmacol 2007;571:25–28.Google Scholar
42.Virmani, A, Gaetani, F, Imam, S, Binienda, Z, Ali, S. The protective role of l-carnitine against neurotoxicity evoked by drug of abuse, methamphetamine, could be related to mitochondrial dysfunction. Ann N Y Acad Sci 2002;965:225–232.Google Scholar
43.Itzhak, Y, Ali, SF. Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs. Pharmacol Ther 2006;109:246–262.CrossRefGoogle ScholarPubMed
44.Davies, KJ. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 1995;61:1–31.Google ScholarPubMed
45.Fagundes, AO, Aguiar, MR, Aguiar, CSet al. Effect of acute and chronic administration of methylphenidate on mitochondrial respiratory chain in the brain of young rats. Neurochem Res 2010;35:1675–1680.Google Scholar
46.Martins, MR, Reinke, A, Petronilho, FC, Gomes, KM, Dal-Pizzol, F, Quevedo, J. Methylphenidate treatment induces oxidative stress in young rat brain. Brain Res 2006;1078:189–197.Google Scholar
47.Van Den Bergh, FS, Bloemarts, E, Chan, JS, Groenink, L, Olivier, B, Oosting, RS. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder. Pharmacol Biochem Behav 2006;83:380–390.Google Scholar
48.Bizot, JC, Chenault, N, Houzé, Bet al. Methylphenidate reduces impulsive behaviour in juvenile Wistar rats, but not in adult Wistar, SHR and WKY rats. Psychopharmacology (Berl) 2007;193:215–223.Google Scholar
49.Calzavara, MB, Medrano, WA, Levin, Ret al. Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia? Schizophr Bull 2009;35:748–759.Google Scholar